The Company should rank amongst the top 100 pharmaceutical companies in India as per ORG.

The Company manufactures drugs and formulations in the form of tablets, capsules, ointment and liquids. The Company’s products cover the following major therapeutic segments:

1. Analgesics – Anti Inflammatory
2. Anti-Asthmatic
3. Antibiotics
4. Anti-bacterials
5. Vitamins
6. Haematinics
7. Cardiovascular drugs

The Company exports its products to over 40 countries across Africa, South America, South East and Central Asia.

In addition to the above activities, the Company utilizes its facilities for Contract Manufacturing on a principal to principal or on Loan License basis for several large Companies like Novartis, Wockhardt, Cipla, Pfizer, Lupin and Serum.

The Company has well equipped, modern manufacturing testing and packaging facilities at all its plants viz. Pimpri,Vadgaon and Vasai. The Pimpri Plant has been approved by Dept. of Science and Technology, Government of India for its R & D facilities. The plants at Vadgaon and Pimpri have also been approved by the Pune University for laboratory use by its students pursuing the Doctorate Degrees

The facilities at Pimpri and Vadgoan are as per the World Health Organisation guidelines and in conformity with Good Manufacturing Practices (GMP), enabling the Company to register its products for exports in several countries all over the world.

The Company also has a well established distribution network all over India (except in Delhi and Uttaranchal) with a customer base of over 1,00, 000 doctors for 145 formulations distributed through 1000 stockists. The domestic marketing personnel comprise of over 600 field force and is registered with several Central and State agencies to cater to the requirements of large hospitals, railways, ESIC’, GMDs, Post and Telegraph Dept. city contractors, autonomous bodies and armed forces. The Company’s business mix also includes an exclusive marketing arrangement with Cipla Ltd. for marketing of its brands across 10 states in the country.